MDGL · Company research
Madrigal Pharmaceuticals, Inc. (MDGL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 487.72 | $15,069,270,917.84 | 14776544917.84 | — | — | — | — | 28.7733060120215992 | 789.95968325854476829521 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.